Hassan, F., Meduru, S., Taguchi, K., Kuppusamy, M. L., Mostafa, M., Kuppusamy, P., & Khan, M. (2012). Carvedilol Enhances Mesenchymal Stem Cell Therapy for Myocardial Infarction via Inhibition of Caspase-3 Expression. The American Society for Pharmacology and Experimental Therapeutics.

Hassan, Fatemat, Sarath Meduru, Kazuaki Taguchi, M. Lakshmi Kuppusamy, Mahmoud Mostafa, Periannan Kuppusamy, a Mahmood Khan. Carvedilol Enhances Mesenchymal Stem Cell Therapy for Myocardial Infarction Via Inhibition of Caspase-3 Expression. The American Society for Pharmacology and Experimental Therapeutics, 2012.

Hassan, Fatemat, et al. Carvedilol Enhances Mesenchymal Stem Cell Therapy for Myocardial Infarction Via Inhibition of Caspase-3 Expression. The American Society for Pharmacology and Experimental Therapeutics, 2012.